Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (5,613,812)	$ 13,534,601
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(87,559)	28,936
Realized investment gains, net	(10,708,155)	(10,143,014)
Unrealized trading (gains) losses included in income	(1,581)	0
Change in fair value of equity securities	14,016,065	(10,838,322)
Amortization of cost of insurance acquired	558,639	581,930
Depreciation	338,550	868,630
Stock-based compensation	218,289	246,534
Charges for mortality and administration of universal life and annuity products	(4,759,240)	(4,839,551)
Interest credited to account balances	3,014,030	3,068,614
Change in accrued investment income	431,837	375,806
Change in reinsurance receivables	122,415	460,659
Change in policy liabilities and accruals	(2,463,865)	(2,458,575)
Change in income taxes receivable (payable)	(458,729)	78,738
Change in other assets and liabilities, net	(3,373,186)	3,749,194
Net cash used in operating activities	(8,766,302)	(5,285,820)
Proceeds from investments sold and matured:
Fixed maturities available for sale	12,253,350	8,563,966
Equity securities	17,071,364	10,219,197
Mortgage loans	554,787	4,824,430
Real estate	8,513,461	11,620,038
Notes receivable	3,689,060	4,296,998
Policy loans	914,651	1,324,183
Short-term investments	10,500,000	0
Total proceeds from investments sold and matured	53,496,673	40,848,812
Cost of investments acquired:
Fixed maturities available for sale	(9,038,928)	(11,655,148)
Equity securities	(12,011,489)	(1,323,310)
Trading securities	5,584	(132,518)
Mortgage loans	(12,692,488)	(4,216,644)
Real estate	0	(1,729,000)
Notes receivable	(3,500,000)	(8,532,796)
Policy loans	(838,766)	(973,594)
Short-term investments	(7,890,228)	0
Total cost of investments acquired	(45,966,315)	(28,563,010)
Net cash provided by investing activities	7,530,358	12,285,802
Cash flows from financing activities:
Policyholder contract deposits	3,386,396	3,542,562
Policyholder contract withdrawals	(3,040,660)	(3,578,980)
Purchase of treasury stock	(3,174,230)	(849,265)
Non controlling contributions (distributions) of consolidated subsidiary	0	(535,662)
Net cash used in financing activities	(2,828,494)	(1,421,345)
Net increase (decrease) in cash and cash equivalents	(4,064,438)	5,578,637
Cash and cash equivalents at beginning of period	28,787,629	20,150,162
Cash and cash equivalents at end of period	$ 24,723,191	$ 25,728,799